JP2002500651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002500651A5 JP2002500651A5 JP1999500127A JP50012799A JP2002500651A5 JP 2002500651 A5 JP2002500651 A5 JP 2002500651A5 JP 1999500127 A JP1999500127 A JP 1999500127A JP 50012799 A JP50012799 A JP 50012799A JP 2002500651 A5 JP2002500651 A5 JP 2002500651A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK0620/97 | 1997-05-29 | ||
| DK62097 | 1997-05-29 | ||
| PCT/DK1998/000220 WO1998053820A1 (en) | 1997-05-29 | 1998-05-28 | Treatment of schizophrenia and psychosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002500651A JP2002500651A (ja) | 2002-01-08 |
| JP2002500651A5 true JP2002500651A5 (enExample) | 2006-01-05 |
Family
ID=8095640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50012799A Ceased JP2002500651A (ja) | 1997-05-29 | 1998-05-28 | 精神分裂病及び精神病の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6297262B1 (enExample) |
| EP (1) | EP1014974B1 (enExample) |
| JP (1) | JP2002500651A (enExample) |
| AT (1) | ATE273007T1 (enExample) |
| AU (1) | AU7639598A (enExample) |
| DE (1) | DE69825605T2 (enExample) |
| ES (1) | ES2227836T3 (enExample) |
| PT (1) | PT1014974E (enExample) |
| WO (1) | WO1998053820A1 (enExample) |
| ZA (1) | ZA984633B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091357B2 (en) * | 2001-12-26 | 2006-08-15 | University Of Kentucky Research Foundation | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies |
| ES2660765T3 (es) | 2004-06-21 | 2018-03-26 | The Board Of Trustees Of The Leland Stanford Junior University | Genes y rutas expresadas de forma diferencial en trastorno bipolar y/o trastorno depresivo mayor |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| CA2620333A1 (en) * | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Ｐｄｅ阻害による神経新生の調節 |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| ES2534672T3 (es) | 2005-11-12 | 2015-04-27 | The Board Of Trustees Of The Leland | Métodos relacionados con FGF2 para diagnosticar y tratar la depresión |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| EP2382975A3 (en) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| JP2010502722A (ja) | 2006-09-08 | 2010-01-28 | ブレインセルス，インコーポレイティド | ４−アシルアミノピリジン誘導体を含む組み合わせ |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| CA2875674A1 (en) | 2012-06-05 | 2013-12-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating psychiatric disorders or symptoms thereof using ncam peptide mimetics |
| WO2017147104A1 (en) * | 2016-02-24 | 2017-08-31 | Chase Pharmaceuticals Corporation | Muscarinic m2-antagonist combinations |
| WO2018039159A1 (en) * | 2016-08-22 | 2018-03-01 | Chase Pharmaceuticals Corporation | Muscarinic m2-antagonist combination |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE845612A (fr) | 1976-03-23 | 1977-02-28 | Derives de tetrazole-5-carboxamide et leur preparation | |
| DE3421072A1 (de) | 1984-06-06 | 1985-12-12 | Heinrich Mack Nachf., 7918 Illertissen | 1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| ES2061502T3 (es) | 1986-06-27 | 1994-12-16 | Beecham Group Plc | Nuevos n-heterociclos biciclicos puenteados. |
| IL83275A (en) | 1986-09-08 | 1994-02-27 | Novo Nordisk As | Substituted 1, 2, 4- oxadiazolyl piperidine compounds, their preparation and pharmaceutical compositions containing them |
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| GB8717446D0 (en) | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| US5405853A (en) | 1987-09-10 | 1995-04-11 | Merck Sharpe & Dohme Ltd. | Thiadiazoles useful in the treatment of senile dementia |
| US5043345A (en) | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| US5328925A (en) | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
| US5073560A (en) | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
| IE922270A1 (en) | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
| US5330994A (en) | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
| DE69332641T2 (de) | 1992-08-31 | 2003-11-27 | University Of Florida Research Foundation, Inc. | Anabasein derivate zur behandlung von degenerativen erkrankungen des nervensystems |
| IL106877A (en) | 1992-09-10 | 1998-03-10 | Lilly Co Eli | Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease |
| NZ336597A (en) | 1993-08-19 | 2001-02-23 | Novo Nordisk As | Use of oxa- or thia-diazole substituted pyridines for treatment of schizophrenia |
| US5705512A (en) | 1994-11-10 | 1998-01-06 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
| US5585388A (en) | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| US5691365A (en) | 1995-07-18 | 1997-11-25 | University Of Kentucky Research Foundation | Nicotinic receptor antagonists in the treatment of neuropharmacological disorders |
| US5756501A (en) | 1995-12-13 | 1998-05-26 | American Home Products Corporation | Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents |
| US5739119A (en) | 1996-11-15 | 1998-04-14 | Galli; Rachel L. | Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA |
-
1998
- 1998-05-28 WO PCT/DK1998/000220 patent/WO1998053820A1/en not_active Ceased
- 1998-05-28 AU AU76395/98A patent/AU7639598A/en not_active Abandoned
- 1998-05-28 DE DE69825605T patent/DE69825605T2/de not_active Expired - Fee Related
- 1998-05-28 JP JP50012799A patent/JP2002500651A/ja not_active Ceased
- 1998-05-28 US US09/424,822 patent/US6297262B1/en not_active Expired - Fee Related
- 1998-05-28 ES ES98924064T patent/ES2227836T3/es not_active Expired - Lifetime
- 1998-05-28 AT AT98924064T patent/ATE273007T1/de not_active IP Right Cessation
- 1998-05-28 PT PT98924064T patent/PT1014974E/pt unknown
- 1998-05-28 EP EP98924064A patent/EP1014974B1/en not_active Expired - Lifetime
- 1998-05-29 ZA ZA984633A patent/ZA984633B/xx unknown